|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Investments, at fair value: | ||||||||||||||||
| Non-controlled, non-affiliated investments | ||||||||||||||||
| Non-controlled, affiliated investments | ||||||||||||||||
| Controlled investments | ||||||||||||||||
| Total investments, at fair value: | ||||||||||||||||
| Cash | ||||||||||||||||
| Interest and fees receivable on investments | ||||||||||||||||
| Dividends receivable | ||||||||||||||||
| Receivable due on investments sold and repaid | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Financing arrangements (net of unamortized debt issuance costs of $14,903 and $14,263, respectively) | ||||||||||||||||
| Payable for investments purchased | ||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||
| Interest payable | ||||||||||||||||
| Accrued management fees | ||||||||||||||||
| Accrued subordinated incentive fee on income | ||||||||||||||||
| Accrued administrative services expense | ||||||||||||||||
| Shareholder distribution payable | ||||||||||||||||
| Share repurchases payable | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Shareholders' Equity | ||||||||||||||||
| Common stock, $0.001 par value; 500,000,000 shares authorized; 49,202,704 and 51,420,629 shares issued and 49,202,704 and 51,417,866 shares outstanding, respectively | ||||||||||||||||
| Capital in excess of par value | ||||||||||||||||
| Accumulated distributable losses | ||||||||||||||||
| Total shareholders' equity | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
| Net asset value per share of common stock at end of period (in dollars per share) |
Loading...
